Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has signed a licence and supply agreement with Russia-based Biocad to start investing in tumor treatment.
Under the deal, Julphar will collaborate with Biocad to register and produce three medicines in the UAE.
Biocad is a Russian leading firm specialised in the biotechnology sector.
